Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global Trends in Incidence Rates of Primary Adult Liver Cancers: A Systematic Review and Meta-Analysis
Paramita Dasgupta, Chloe Henshaw, Danny R. Youlden, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 208

Showing 1-25 of 208 citing articles:

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis
Oliver Clements, Joseph Eliahoo, Jin Un Kim, et al.
Journal of Hepatology (2019) Vol. 72, Iss. 1, pp. 95-103
Closed Access | Times Cited: 412
Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future Prospects
Basil Alawyia, Constantina Constantinou
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 7, pp. 711-724
Closed Access | Times Cited: 71
CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma
Laurence P. Diggs, Benjamin Ruf, Chi Ma, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 5, pp. 1145-1154
Open Access | Times Cited: 107
Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell‐free DNA fragmentomics
Xiangyu Zhang, Zheng Wang, Wanxiangfu Tang, et al.
Hepatology (2021) Vol. 76, Iss. 2, pp. 317-329
Closed Access | Times Cited: 72
The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma
Joan Ericka Flores, Alexander Thompson, Marno Ryan, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 793-793
Open Access | Times Cited: 58
Prevention strategies for sexually transmitted infections, HIV, and viral hepatitis in Europe
Deniz Gökengin, Teymur Noori, Andrea Alemany, et al.
The Lancet Regional Health - Europe (2023) Vol. 34, pp. 100738-100738
Open Access | Times Cited: 30
Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review
Ashraf Elbahrawy, Hassan Atalla, Mohamed Alboraie, et al.
Viruses (2023) Vol. 15, Iss. 1, pp. 214-214
Open Access | Times Cited: 27
Experimental mouse models for translational human cancer research
Yinxi Zhou, Jinghua Xia, Shuonan Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Immunotherapy for hepatocellular carcinoma
Alexa Childs, Gloryanne Aidoo-Micah, Mala K. Maini, et al.
JHEP Reports (2024) Vol. 6, Iss. 10, pp. 101130-101130
Closed Access | Times Cited: 12
Tumor Mutational Burden from Circulating Tumor DNA Predicts Recurrence of Hepatocellular Carcinoma After Resection: An Emerging Biomarker for Surveillance
Chase J. Wehrle, Hanna Hong, Suneel D. Kamath, et al.
Annals of Surgery (2024)
Closed Access | Times Cited: 11
Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
George Lau, Ghassan K. Abou‐Alfa, Ann‐Lii Cheng, et al.
Journal of Hepatology (2024) Vol. 82, Iss. 2, pp. 258-267
Open Access | Times Cited: 10
Overview of Salvia miltiorrhiza as a Potential Therapeutic Agent for Various Diseases: An Update on Efficacy and Mechanisms of Action
In-Yong Jung, Hyerin Kim, Seongcheol Moon, et al.
Antioxidants (2020) Vol. 9, Iss. 9, pp. 857-857
Open Access | Times Cited: 69
Resolution of eicosanoid/cytokine storm prevents carcinogen and inflammation-initiated hepatocellular cancer progression
Anna Fishbein, Weicang Wang, Haixia Yang, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 35, pp. 21576-21587
Open Access | Times Cited: 66
Synthesis of new substituted pyridine derivatives as potent anti-liver cancer agents through apoptosis induction: In vitro, in vivo, and in silico integrated approaches
Ahmed T. A. Boraei, Elsayed H. Eltamany, Imran Ali, et al.
Bioorganic Chemistry (2021) Vol. 111, pp. 104877-104877
Closed Access | Times Cited: 55
Drug-eluting embolic microspheres: State-of-the-art and emerging clinical applications
Andrew S. Mikhail, Ayele H. Negussie, Michal Mauda‐Havakuk, et al.
Expert Opinion on Drug Delivery (2021) Vol. 18, Iss. 3, pp. 383-398
Open Access | Times Cited: 45
Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly
Young Eun Chon, Sung Yong Park, Hanpyo Hong, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. 1, pp. 120-134
Open Access | Times Cited: 36
The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review
Agnieszka Kopystecka, Rafał Patryn, Magdalena Leśniewska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9342-9342
Open Access | Times Cited: 19
Cancer-on-chip: a 3D model for the study of the tumor microenvironment
Elisa Cauli, Michela Anna Polidoro, Simona Marzorati, et al.
Journal of Biological Engineering (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 19
The Synergistic Effect of Interventional Locoregional Treatments and Immunotherapy for the Treatment of Hepatocellular Carcinoma
Nicolò Brandi, Matteo Renzulli
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8598-8598
Open Access | Times Cited: 18
Diethylnitrosamine Induction of Hepatocarcinogenesis in Mice
Jules Sotty, Pierre Bablon, Paul-Henry Weiss, et al.
Methods in molecular biology (2024), pp. 15-25
Closed Access | Times Cited: 6
Current and Emerging Tools for Hepatocellular Carcinoma Surveillance
Nia Adeniji, Renumathy Dhanasekaran
Hepatology Communications (2021) Vol. 5, Iss. 12, pp. 1972-1986
Open Access | Times Cited: 40
Targeting Lymphangiogenesis and Lymph Node Metastasis in Liver Cancer
Sukanya Roy, Priyanka Banerjee, Burcin Ekser, et al.
American Journal Of Pathology (2021) Vol. 191, Iss. 12, pp. 2052-2063
Open Access | Times Cited: 35
Hepatocellular Carcinoma in Sub-Saharan Africa
V V Pavan Kedar Mukthinuthalapati, Vikash Sewram, Ntokozo Ndlovu, et al.
JCO Global Oncology (2021), Iss. 7, pp. 756-766
Open Access | Times Cited: 33
Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990–2019: a longitudinal analysis based on the global burden of disease study
Maedeh Amini, Mehdi Azizmohammad Looha, Elaheh Zarean, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes
Vivek P. Chavda, Kelsee K. Zajac, Jenna Lynn Gunn, et al.
Cancer Reports (2023) Vol. 6, Iss. S1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top